EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The antibacterial activity and therapeutic potential of the amphibian-derived peptide TB_KKG6K

Cristina Schöpf iD, Magdalena Knapp, Jakob Scheler, Débora C Coraça-Huber iD, Alessandra Romanelli, Peter Ladurner, Anna C Seybold, Ulrike Binder, Reinhard Würzner, Florentine Marx iD

mSphere · 2025

DOI: 10.1128/msphere.01016-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mSphere, 2025. Verfasst von Cristina Schöpf und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biocenter, Institute of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Staphylococcus aureus, Antimicrobial Cationic Peptides, Antimicrobial Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Austrian Science Fund, Tiroler Nachwuchsforscher*innenfoerderung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antimicrobial peptides (AMPs) have great potential to be developed as topical treatments for microbial infections of the skin, including those caused by the gram-positive human pathogen Staphylococcus aureus . Among the AMPs, temporin B (TB) is of particular interest. This 13-amino-acid-long cationic peptide is secreted by the granular glands of the European frog Rana temporaria and represents a primary line of defense against invading pathogens. The objective of this study was to investigate the antibacterial efficacy and the mode of action of the synthetic TB analog, TB_KKG6K, in a drug-resistant clinical isolate of S. aureus and assess the peptide’s tolerance and curative potential in an in vitro infection model using three-dimensional human epidermis equivalents (HEEs). The results revealed a high bactericidal efficacy of TB_KKG6K at low micromolar concentrations. The peptide perturbed the bacterial cell membrane integrity by permeabilization and depolarization. TB_KKG6K showed no toxicity in the invertebrate mini-host model Galleria mellonella and a high level of tolerance when topically applied in HEEs. Importantly, the therapeutic potential of TB_KKG6K was confirmed in HEEs infected with S. aureus . The topical application of TB_KKG6K significantly reduced the bacterial load and lowered the pro-inflammatory response in the infected HEEs. These findings reinforce the antibacterial potential and therapeutic efficacy of TB_KKG6K against S. aureus infection, particularly in the context of a cutaneous infection. IMPORTANCE The emergence of multidrug-resistant bacteria has rendered the exploration of novel therapeutic treatment strategies a pivotal area of research. Among the most promising candidates are amphibian-derived antimicrobial peptides (AMPs), which are ideal for the development of novel drugs due to their multifaceted mode of action. Extensive studies have been conducted on these peptides over the last decade, resulting in the development of temporin B (TB) peptide analogs that have undergone modifications to their primary sequence. These modified analogs have demonstrated enhanced antibacterial and antifungal efficacy, while exhibiting reduced hemolytic activity. TB_KKG6K has the potential to be a promising candidate for topical treatments due to its small size and high antimicrobial activity against pathogens of the human skin. In particular, it demonstrated efficacy against Staphylococcus aureus , a skin commensal that can become an opportunistic pathogen, causing a range of infections from minor skin infections to life-threatening diseases such as bacteremia and sepsis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsStaphylococcus aureusAntimicrobial Cationic PeptidesAntimicrobial PeptidesAmphibian ProteinsAnimalsHumansMicrobial Sensitivity TestsRana temporariaStaphylococcal Infections

Stichwörter der Autor:innen

Staphylococcus aureusantibacterial activityantimicrobial peptidehuman epidermis equivalentmembrane activitytemporin B analog

Substanzen

Anti-Bacterial AgentsAntimicrobial Cationic PeptidesAntimicrobial PeptidesAmphibian Proteinstemporin

Autor:innen und Institutionen

  • Biocenter, Institute of Molecular Biology, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Zoology, University of Innsbruck, Innsbruck, Austria.
  • Institute of Hygiene and Medical Microbiology, Medical University of Innsbruck, Innsbruck, Austria.
  • Research Laboratory for Implant Associated Infections (BIOFILM LAB), Experimental Orthopaedics, University Hospital for Orthopaedics and Traumatology, Medical University of Innsbruck, Innsbruck, Austria.
  • Department of Pharmaceutical Sciences, University of Milan, Milan, Italy.

ORCID-Profile: Cristina Schöpf, Débora C Coraça-Huber, Florentine Marx

Förderung

  • Austrian Science Fund
  • Tiroler Nachwuchsforscher*innenfoerderung

Zitieren

APA

Schöpf, C., Knapp, M., Scheler, J., Coraça-Huber, D. C., Romanelli, A., Ladurner, P., Seybold, A. C., Binder, U., Würzner, R., & Marx, F. (2025). The antibacterial activity and therapeutic potential of the amphibian-derived peptide TB_KKG6K. mSphere. https://doi.org/10.1128/msphere.01016-24

Vancouver

Schöpf C, Knapp M, Scheler J, Coraça-Huber DC, Romanelli A, Ladurner P, et al. The antibacterial activity and therapeutic potential of the amphibian-derived peptide TB_KKG6K. mSphere. 2025. doi:10.1128/msphere.01016-24

BibTeX
@article{Schpf2025,
  author = {Schöpf, Cristina and Knapp, Magdalena and Scheler, Jakob and Coraça-Huber, Débora C and Romanelli, Alessandra and Ladurner, Peter and Seybold, Anna C and Binder, Ulrike and Würzner, Reinhard and Marx, Florentine},
  title = {The antibacterial activity and therapeutic potential of the amphibian-derived peptide TB_KKG6K},
  journal = {mSphere},
  year = {2025},
  doi = {10.1128/msphere.01016-24}
}
Kostenlos starten →